Oric Pharmaceuticals Stock Momentum Indicators Minus Directional Indicator

ORIC Stock  USD 9.02  0.47  4.95%   
Oric Pharmaceuticals momentum indicators tool provides the execution environment for running the Minus Directional Indicator indicator and other technical functions against Oric Pharmaceuticals. Oric Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Minus Directional Indicator indicator function is designed to identify and follow existing trends. Momentum indicators of Oric Pharmaceuticals are pattern recognition functions that provide distinct formation on Oric Pharmaceuticals potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Minus Directional indicator describes the rate of negative changes that contributes to the overall Oric Pharmaceuticals price trend.

Oric Pharmaceuticals Technical Analysis Modules

Most technical analysis of Oric Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oric from various momentum indicators to cycle indicators. When you analyze Oric charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Oric Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oric Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oric Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Oric Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oric Pharmaceuticals's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Oric Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Oric Pharmaceuticals, we also check how macroeconomic factors affect Oric Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Current Ratio15.8713.6810.3918.35
Net Debt To EBITDA2.870.70.120.11
Hype
Prediction
LowEstimatedHigh
5.069.0212.98
Details
Intrinsic
Valuation
LowRealHigh
5.038.9912.95
Details
Naive
Forecast
LowNextHigh
5.839.7813.74
Details
12 Analysts
Consensus
LowTargetHigh
14.4315.8617.60
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oric Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oric Pharmaceuticals' short interest history, or implied volatility extrapolated from Oric Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Business Services Idea
Business Services
Invested few shares
Momentum Idea
Momentum
Invested few shares
Impulse Idea
Impulse
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested few shares
Trump Equities Idea
Trump Equities
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
When determining whether Oric Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oric Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oric Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oric Pharmaceuticals Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oric Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric Pharmaceuticals. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.82)
Return On Assets
(0.29)
Return On Equity
(0.46)
The market value of Oric Pharmaceuticals is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oric Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oric Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.